Cutaneous angiosarcoma (CAS) is a highly aggressive cancer with a poor prognosis.
Primary, spontaneous CAS (pCAS) and secondary, post‐irradiation‐or lymphedema …

Cutaneous vascular tumors constitute a heterogeneous group of entities that share
overlapping morphologic and immunohistochemical features, which can be diagnostically …

Background Systemic treatments for angiosarcoma remains an area of unmet clinical need.
The authors conducted this retrospective study to assess the clinical activity of checkpoint …

Angiosarcomas are ubiquitous neoplasms involving both cutaneous and soft tissue and
visceral locations. Accumulating biomolecular evidences suggest that cutaneous …

Angiosarcomas (AS) are a diverse group of soft tissue sarcomas, arising from blood and
lymphatic vessels. They frequently present in the elderly, and in patients with previous …

Vascular neoplasms account for a substantial fraction of cutaneous mesenchymal tumors,
spanning from clinically indolent benign lesions to highly aggressive malignancies. These …

Dermatofibrosarcoma protuberans (DFSP) is a low-grade cutaneous sarcoma with an
approximate yearly incidence of 4 cases per million in the United States (Tables 1 and 2). 1 …

Cutaneous mesenchymal sarcomas develop from the soft tissue of the dermis and subcutis.
Given the overall rarity of these cutaneous malignancies, limited consensus guidelines exist …

Angiosarcoma is a rare but often fatal malignancy from blood and lymphatic vessels that can
arise anywhere in the body and often affects the head and neck region. Although its dismal …

The management of non-melanoma skin cancers metastatic to the neck is challenging due
to variability in biological behavior and patterns of regional lymphatic spread. Metastatic non …